Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001193125-20-291681
| Metric | Q3 2020 | Q3 2019 |
|---|---|---|
| Net Income | -$36.08M | -$19.67M |
| EPS Diluted | -$3.00 | -$5.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
